Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Emles Advisors Announces Closure of Six Funds PR Newswire NEW YORK, Sept. 16, 2022 NEW YORK, Sept. 16, 2022 /PRNewswire/ -- Due to the inability...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Trial Designed to Tackle HIV Drug Resistance (One or More of a Patient's Current HIV Drug...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Data Shows 0.4 log10 Difference Between the High-Dose and the Placebo Control Group ? -- Dose...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Clears Clogged Arteries ? -- Raises HDL ? -- Reduces CK Enzyme Marker: Suggesting It...
Samaritan Pharmaceuticals (AMEX:LIV): ? -- Completed Phase II Stage 1 (10 Day Monotherapy) ? -- Expect to Report Stage I Preliminary Results...
The Samaritan Foundation and Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today on National DNA day, it...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) ? -- David W. Munno, Merrill Lynch VP of biotechnology, stated, "Large-cap biotech firms need some...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its shareholders are invited to the Annual...
Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- PII/III HIV Oral Entry Inhibitor Drug ? -- Cardiovascular Drug SP-1000 ? -- Alzheimer's Drug...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지